EGFR and head and neck squamous cell carcinoma: A recent retrospective study [20] evaluated the EGFR expression in 155 patients with stage III-IV SCCHN accrued in the control arm of RTOG 9003 study, and received exclusive external beam RT (70 Gy in 7 weeks).